Remzistotug

DRUG2 trials

Sponsors

GlaxoSmithKline

Conditions

NeoplasmsNeoplasms, Head and Neck

Phase 1

First-Time-in-Human Study of GSK4381562 in Participants With Advanced Solid Tumors

Active, not recruitingNCT05277051

GlaxoSmithKlineNeoplasms

Start: 2022-03-22End: 2027-08-31Updated: 2026-03-23

Phase 2

A Platform Study of Novel Immunotherapy Combinations as First-Line Treatment in Participants With PD-L1 Positive Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck- GALAXIES H&N-202

Active, not recruitingNCT06062420

GlaxoSmithKlineNeoplasms, Head and Neck

Start: 2023-11-14End: 2027-07-22Updated: 2026-01-09